Semaglutide Medication class: Semaglutide is a GLP-1 receptor agonist Tirzepatide acts on both GLP-1 and GIP receptors Use: Both are injectable prescription medications used alongside diet and exercise to support blood sugar regulation and weight management in adults Dosing: Both medications are typically administered as a once-weekly injection, based on individual treatment plans Effect profile: Both work by influencing appetite regulation and glucose metabolism Individual response and tolerance may vary Side effects: Common side effects may include nausea, vomiting, diarrhea, constipation, or abdominal discomfort Side effects and tolerability differ between individuals Treatment selection: Choice of medication is based on medical history, clinical evaluation, and provider recommendation Formulation: At NP ON DEMAND, these medications may be provided as compounded formulations, which may include bacteriostatic water (BAC), vitamin B12, or glycine, depending on individual treatment plans Who Should Not Use GLP-1 Medications

If you are taking a GLP 1 medicine you should not stop it suddenly on your own
[4][6] $200/month maximum for Wegovy and Zepbound Savings can reach $3,600+ per year compared to direct-to-consumer cash programs Simplified prior authorization designed to speed up access Available only if your employer opts in not automatic for all Cigna plans Questions to ask Cigna or HR: "Is my plan enrolled in the Evernorth $200/month GLP-1 cost cap?" "If so, does it apply to Wegovy specifically?" Express Scripts answers depend on your plan type
Robert Popovian joining us from our nations capitol, a pharmacist, economist and Chief Science Policy Officer at the Global Healthy Living Foundation
For human therapeutic applications, follow your healthcare providers guidance and product labeling